• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Axiogenesis AG


Ticker Delisted

Snapshot for Axiogenesis AG (AI8)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for AI8

No chart data available.
  • AI8:GR
  • 1M
  • 1Y
Interactive AI8 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AI8

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.15
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AI8

No data available

Company Profile & Key Executives for AI8

Axiogenesis AG is a biotechnology company. The Company develops novel assays that use differentiated embryonic stem cell that display normal physiological behavior. Axiogenesis products are used in pharmacology and safety screening in the pharmaceutical, chemical, and cosmetics industries.

Heribert BohlenCEO/Member:Executive BoardBernd FronholffCFO/COO/Member:Executive Board
More Company Profile & Key Executives for AI8

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil